ASX/1AI (ASX/1AI)

Australian Securities Exchange: ASX/1AI · AUD

A$0.01

+0.00 (+5.3%)· Recorded snapshot

Market cap	20.3M
Net income (ttm)	-2.7M
EPS (ttm)	-A$0.00
Shares out	2B
Volume	1,119,060
Beta	-0.07

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -2.7M
EPS (ttm): -A$0.00
Market cap: 20.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-83.5

P25 -108P50 -50.6P75 1.1

ROIC-44.2

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/1AI indicators

Market & fundamental data

Available fields

159

Groups with data

Currency

AUD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-10-29
Employees	48
Enterprise value	AUD 16.3M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1987
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000LCT6
Last earnings date	2026-02-24
Last refreshed	2026-10-29
Market cap	AUD 20.3M
Next earnings date	2026-10-29
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	asx/1AI
Website	https://algoraepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-15.27%
FCF / EV yield	-15.94%
FCF yield	-12.84%
Industry forward P/E	28.51x
P/B ratio	4.76x
Price / tangible book value	4.76x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	AUD -56,473
ROA	-41.93%
ROA (5Y)	-29.56%
ROCE	-53.81%
ROE	-83.53%
ROE (5Y)	-60.48%
ROIC	-44.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	AUD -2.3M
EPS	AUD -0.00
FCF per share	AUD -0.00
Financing cash flow	AUD 4.2M
Free cash flow	AUD -2.6M
Free cash flow minus SBC	AUD -3.1M
Income taxes	AUD -384,467
Investing cash flow	AUD 1.1M
Net cash flow	AUD 2.7M
Net income	AUD -2.7M
Operating cash flow minus SBC	AUD -3.1M
Operating income	AUD -2.3M
Stock-based compensation	AUD 490,003

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	AUD 0.00
Debt / equity	0
Interest coverage	-84.93
Long-term assets	AUD 0
Long-term liabilities	AUD 0
Net cash (debt)	AUD 3.9M
Net cash / market cap	19.42%
Net cash growth	69.77%
Net debt / equity	-0.92
Piotroski F-Score	2
Shareholders' equity	AUD 4.3M
Tangible book value	AUD 4.3M
Tangible book value per share	AUD 0.00
Total assets	AUD 4.4M
Total cash	AUD 3.9M
Total debt	AUD 0
Total liabilities	AUD 176,721
WACC	3.87%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	AUD 4.4M
Current liabilities	AUD 176,721
Current ratio	25.11
Net working capital	AUD 324,011
Quick ratio	22.75
Working capital	AUD 4.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-5.15%
Shareholder yield	-5.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-87.5%
10Y return CAGR	-18.31%
10Y total return	-86.76%
150-day SMA	AUD 0.01
15Y price change	-85.51%
15Y return CAGR	-11.74%
15Y total return	-84.64%
1D price change	5.26%
1M price change	11.11%
1M total return	11.11%
1Y price change	11.11%
1Y return CAGR	11.12%
1Y total return	11.11%
20-day SMA	AUD 0.01
200-day SMA	AUD 0.01
20Y price change	-95%
20Y return CAGR	-13.66%
20Y total return	-94.7%
3M price change	-16.67%
3M total return	-16.67%
3Y price change	-16.67%
3Y return CAGR	-5.9%
3Y total return	-16.67%
50-day SMA	AUD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.02
52-week high date	2026-02-06
52-week low	AUD 0.01
52-week low date	2026-10-14
5Y price change	25%
5Y return CAGR	5.79%
5Y total return	32.47%
6M price change	-28.57%
6M total return	-28.57%
All-time high	AUD 0.62
All-time high date	2004-11-05
All-time low	AUD 0.00
All-time low date	2022-01-25
Average true range (ATR)	AUD 0.00
Average volume	784.8K
Beta (1Y)	0.23
Beta (2Y)	0.55
Beta (5Y)	-0.07
Change from 52-week high	-58.33%
Change from 52-week low	25%
Change from all-time high	-98.39%
Change from all-time low	150%
Change from open	0%
Day's gap	5.26%
Dollar volume	AUD 11,191
High price	AUD 0.01
Low price	AUD 0.01
Monthly RSI	48.09
Open price	AUD 0.01
Previous close	AUD 0.01
Price vs 150-day SMA	-14.53%
Price vs 20-day SMA	11.11%
Price vs 200-day SMA	-24.81%
Price vs 50-day SMA	3.09%
Relative volume	1.43
RSI	56.65
Sharpe ratio	0.48
Sharpe ratio (3Y)	0.47
Sharpe ratio (5Y)	0.53
Sortino ratio	0.82
Sortino ratio (3Y)	0.79
Sortino ratio (5Y)	0.87
Volume	1.1M
Weekly RSI	45.34
YTD price change	-28.57%
YTD total return	-28.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.4B
Shares change (QoQ)	10.25%
Shares change (YoY)	5.15%
Shares held by insiders	16.05%
Shares held by institutions	1.01%
Shares outstanding	2B

Deeper analysis on ASX/1AI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/1AI report

Is a complete ASX/1AI research report available?

No complete published report is available for asx/1AI (ASX/1AI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/1AI (ASX/1AI)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/1AI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/1AI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/1AI

Frequently asked questions